Rabeprazole Sodium Delayed Release Tablets
Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- SPE2D220R0061
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency (DLA) Troop Support Medical is planning to issue a solicitation for a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The contract will establish a national supply source to provide the Rabeprazole Sodium DR 20MG tablets in 30, 90, and 500 count bottles to Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. This will be an unrestricted and fully competitive acquisition, solicited using FAR Part 12 for commercial items. Interested parties should contact Phyllis Daraio for any questions and set up automated notifications of pre-solicitation or solicitation changes. The current projected solicitation date is February 2020, but DLA reserves the right to issue the solicitation before or after this date.
This is an unrestricted acquisition with no set-aside designation. The historical contract details provided indicate that the contract has been awarded to GSMS, Inc. and has had several modifications exercising option years. The annual estimated usage quantities will be provided in the solicitation. No specific award value or budget range was provided in the pre-solicitation notice.
Notice text
5 versions
Update #5 · Latest ·
Modification P00008 SPE2D220D0096 has been issued to invoke option year 4 effective August 27, 2024 through August 26, 2025. All other terms and conditions remain unchanged.
Update #4 ·
Modification P00003 SPE2D220D0096 has been issued to invoke option year 2 effective August 27, 2022 through August 26, 2023.
Modification P00002 SPE2D220D0096 has been issued to invoke option year 1 effective August 27, 2021 through August 26, 2022.
Modification P00001 SPE2D220D0096 to incorporate FAR 52.204-24 and FAR 52.204-25 into subject contract.
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. Procurement details follow.
Rabeprazole Sodium DR 20MG in 30, 90 and 500 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual estimated usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Phyllis Daraio (215-737-7941) email phyllis.daraio@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is February of 2020. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Update #3 ·
Modification P00002 SPE2D220D0096 has been issued to invoke option year 1 effective August 27, 2021 through August 26, 2022.
Modification P00001 SPE2D220D0096 to incorporate FAR 52.204-24 and FAR 52.204-25 into subject contract.
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. Procurement details follow.
Rabeprazole Sodium DR 20MG in 30, 90 and 500 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual estimated usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Phyllis Daraio (215-737-7941) email phyllis.daraio@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is February of 2020. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Update #2 ·
Modification P00001 SPE2D220D0096 to incorporate FAR 52.204-24 and FAR 52.204-25 into subject contract.
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. Procurement details follow.
Rabeprazole Sodium DR 20MG in 30, 90 and 500 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual estimated usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Phyllis Daraio (215-737-7941) email phyllis.daraio@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is February of 2020. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Update #1 ·
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. Procurement details follow.
Rabeprazole Sodium DR 20MG in 30, 90 and 500 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual estimated usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Phyllis Daraio (215-737-7941) email phyllis.daraio@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is February of 2020. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| Rabeprazole Sodium Delayed Release Tablets | Award Notice | |
| Rabeprazole Sodium Delayed Release Tablets | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| PRAZIQUANTEL TABLET and 5 more items | Medical Supply Chain | No set-aside | |
| Docusate sodium capsu | Medical Supply Chain | No set-aside | |
| Fluconazole tablets | Medical Supply Chain | No set-aside | |
| Sodium perborate | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity